Ana Cespedes
Director/Board Member en ARGENX SE .
Fortuna: 88 962 $ al 31/03/2024
Perfil
Ana Cespedes is the founder of Spanish Women Leaders Life Science.
She currently holds multiple positions, including Independent Non-Executive Director at argenx SE, Director at the University of Navarra, Chief Operating Officer at the International AIDS Vaccine Initiative, Inc., Member at the London School of Economics & Political Science, Member-Oncology Data at the National Institutes of Health, Member at Living Mindfulness SL, and Member at Congreso de los Diputados.
In her former roles, she served as Managing Director at Merck Healthcare Foundation and Serono Iberia, Head-Corporate Affairs at Merck SL, and Senior Vice President-Global Marketing & Strategy at Merck KGAA Unsponsored ADR Facility.
Dr. Cespedes obtained an MBA from the University of Navarra and completed undergraduate and doctorate degrees at Universidad Complutense de Madrid.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARGEN-X SE
0.00% | 20/02/2024 | 225 ( 0.00% ) | 88 962 $ | 31/03/2024 |
Cargos activos de Ana Cespedes
| Empresas | Cargo | Inicio |
|---|---|---|
| ARGENX SE | Director/Board Member | 12/12/2022 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Chief Operating Officer | - |
| London School of Economics & Political Science | Corporate Officer/Principal | - |
| Congreso de los Diputados | Corporate Officer/Principal | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| University of Navarra | Director/Board Member | - |
Antiguos cargos conocidos de Ana Cespedes.
| Empresas | Cargo | Fin |
|---|---|---|
Merck SL
 Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The private company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Corporate Officer/Principal | - |
| Merck KGAA Unsponsored ADR Facility | Sales & Marketing | - |
Formación de Ana Cespedes.
| Universidad Complutense de Madrid | Doctorate Degree |
| University of Navarra | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Empresas privadas | 5 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| Merck KGAA Unsponsored ADR Facility | |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Merck SL
Merck SL Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, Merck SL is a Spanish company that manufactures pharmaceutical products. The private company is based in Madrid, Spain. The company was founded in 1949. The CEO is Laura González Molero. | Health Technology |
| Congreso de los Diputados | Government |
- Bolsa de valores
- Insiders
- Ana Cespedes
